Isolation of an acidic phospholipase A2 from the venom of the snake Bothrops asper of Costa Rica: Biochemical and toxicological characterization

Biochimie

Volumn 92, Issue 3, 2010, Pages 273-283

  Fernández, Julián ^a   Gutiérrez, José María ^a   Angulo, Yamileth ^a   Sanz, Libia ^b   Juárez, Paula ^b   Calvete, Juan J ^b   Lomonte, Bruno ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

BaspPLA2 II; Bothrops asper; Phospholipase A2; Snake venom

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BOTHROPS ASPER; CELL AGGREGATION; CONTROLLED STUDY; COSTA RICA; CYTOTOXICITY; HUMAN; IMMUNOCHEMISTRY; ISOELECTRIC POINT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN ANALYSIS; PROTEIN ISOLATION; SEQUENCE ALIGNMENT; SNAKE; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMALS; BOTHROPS; CELLS, CULTURED; COSTA RICA; CROTALID VENOMS; EDEMA; HUMANS; ISOENZYMES; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PHOSPHOLIPASES A2; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; RABBITS; SEQUENCE ALIGNMENT;

BOTHROPS; BOTHROPS ASPER; MUS;

EID: 77649275988     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.12.006     Document Type: Article

References (58)

1. Gutiérrez J.M. Clinical toxicology of snakebite in Central America. Handbook of Clinical Toxicology of Animal Venoms and Poisons 1995, 645-665. CRC Press, Boca Raton. J. Meier, J. White (Eds.).
2. Sasa M., Vázquez S. Snakebite envenomation in Costa Rica: a revision of incidence in the decade 1990-2000. Toxicon 2003, 41:19-22.
3. Alape-Girón A., Sanz L., Escolano J., Flores-Díaz M., Madrigal M., Sasa M., Calvete J.J. Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations. J. Proteome Res. 2008, 7:3556-3571.
4. 2. Science 1990, 250:1541-1546.
5. 2 enzymes. Toxicon 2003, 42:827-840.
6. 2 Enzymes: Structure, Function and Mechanism 1997, 321-352. Wiley, Chichester. R.M. Kini (Ed.).
7. 2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell. Mol. Life Sci. 2008, 65:2897-2912.
8. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
9. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 2003, 42:885-901.
10. 2 homologues of snake venoms: biological activities and their possible adaptive roles. Protein Pept. Lett. 2009, 16:860-876.
11. Rosenberg P. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. Natural Toxins Animal, Plant and Microbial 1986, 129-174. Oxford Science Publications, Oxford. J.B. Harris (Ed.).
12. 2 from the venom of the common viper, Vipera berus berus. Biochim. Biophys. Acta 1993, 1157:81-85.
13. Rosenberg P. Phospholipases. Handbook of Toxinology 1990, 67-277. Marcel Dekker, New York. W.T. Shier, D. Mebs (Eds.).
14. 2 isolated from Bothrops moojeni snake venom. Toxicon 2008, 52:908-917.
15. 2 from Bothrops lanceolatus (fer de lance) venom: molecular and enzymatic properties. Toxicon 1994, 32:1069-1081.
16. 2 from Bothrops neuwiedii venom. Arch. Biochem. Biophys. 1995, 318:65-70.
17. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 2002, 64:723-732.
18. 2 to the lethal potency of Bothrops alternatus (víbora de la cruz) venom. Toxicon 1986, 24:807-817.
19. 2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor. Arch. Biochem. Biophys. 1999, 367:26-32.
20. 2 isoforms from Bothrops jararacussu snake venom. Biochimie 2003, 10:983-991.
21. 2 from Bothrops pauloensis snake venom. Toxicon 2007, 50:153-165.
22. 2 from Bothrops jararacussu venom. Protein J. 2004, 23:273-285.
23. 2 release by endothelial cells. Biochem. Pharmacol. 2006, 72:377-384.
24. Ferlan I., Gubenšek F. Phospholipases of Bothrops asper venom. Period. Biol. 1978, 80:31-36.
25. 2. Biochem. J. 1980, 185:695-704.
26. 2 variants: identification of isozymes in the venoms of newborn and adult Bothrops asper (terciopelo) snakes. Toxicon 1988, 26:363-371.
27. Gutiérrez J.M., Ownby C.L., Odell G.V. Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon 1984, 22:115-128.
28. Lomonte B., Gutiérrez J.M. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 1989, 27:725-733.
29. 2+ free and bound states. Biochimie 2006, 88:543-549.
30. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL Workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22:195-201.
31. 2 activity by a colorimetric assay using a pH indicator. Toxicon 1987, 25:1181-1188.
32. Dole V.P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. Clin. Invest. 1956, 35:150-154.
33. Gutiérrez J.M., Lomonte B., Chaves F., Moreno E., Cerdas L. Pharmacological activities of a toxic phospholipase a isolated from the venom of the snake Bothrops asper. Comp. Biochem. Physiol. 1986, 84C:159-164.
34. 2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon 1999, 37:145-158.
35. Lomonte B., Gutiérrez J.M., Moreno E., Cerdas L. Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo). Toxicon 1987, 25:443-449.
36. Angulo Y., Estrada R., Gutiérrez J.M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon 1997, 35:81-90.
37. Lomonte B., Gutiérrez J.M., Rojas G., Calderón L. Quantitation by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms. Toxicon 1991, 29:695-702.
38. Pérez A.V., Rucavado A., Sanz L., Calvete J.J., Gutiérrez J.M. Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper. Braz. J. Med. Biol. Res. 2008, 41:12-17.
39. Calvete J.J., Juárez P., Sanz L. Snake venomics. Strategy and applications. J. Mass Spectrom. 2007, 42:1405-1414.
40. 2 from the venom of Bothrops insularis (jararaca ilhoa). Biochimie 2006, 12:1947-1959.
41. Calvete J.J., Sanz L., Angulo Y., Lomonte B., Gutiérrez J.M. Venoms, venomics, antivenomics. FEBS Lett. 2009, 583:1736-1743.
42. Sasa M., Wasko D.K., Lamar W.W. Natural history of the terciopelo Bothrops asper (Serpentes: Viperidae) in Costa Rica. Toxicon 2009, 54:904-922.
43. 2 isoenzyme isolated from Lachesis muta snake venom. Biochem. Pharmacol. 2002, 63:1589-1597.
44. 2 of Crotalus viridis viridis. Arch. Biochem. Biophys. 2003, 411:289-296.
45. 2 homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide. Biochem. Pharmacol. 2000, 59:1289-1294.
46. Teixeira C., Cury Y., Moreira V., Picolo G., Chaves F. Inflammation induced by Bothrops asper venom. Toxicon 2009, 54:988-997.
47. 2 isolated from Lachesis muta (bushmaster) snake venom. Toxicon 2000, 38:961-972.
48. 2-II from Agkistrodon halys pallas. Biochim. Biophys. Acta 1999, 1431:157-165.
49. 2 in the monomeric and dimeric states: insights into its oligomeric state. Biochem. Biophys. Res. Commun. 2004, 323:24-31.
50. 2 from Agkistrodon halys pallas venom. Toxicon 2008, 51:1131-1139.
51. Hayashi M.A., Camargo A.C. The bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme. Toxicon 2005, 45:1163-1170.
52. Ménez A. Molecular immunology of snake toxins. Pharmacol. Ther. 1985, 30:91-113.
53. 2 neurotoxins from snake venoms. Toxicon 1989, 27:965-977.
54. Lomonte B., Gutiérrez J.M., Mata E. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. Toxicon 1985, 23:807-813.
55. Lomonte B., Gutiérrez J.M., Carmona E., Rovira M.E. Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. Toxicon 1990, 28:379-384.
56. 2 from the venom of the snake Bothrops asper by monoclonal antibodies. Toxicon 1992, 30:239-245.
57. Higgins D., Thompson J., Gibson T., Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
58. Dereeper A., Guignon V., Blanc G., Audic S., Buffet S., Chevenet F., Dufayard J.F., Guindon S., Lefort V., Lescot M., Claverie J.M., Gascuel O. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008, 36(web server issue):W465-W469.